SpringWorks Therapeutics, Inc. (SWTX) Income Quarterly - Discounting Cash Flows
SWTX
SpringWorks Therapeutics, Inc.
SWTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
Report Filing 2025-05-09 2025-05-09 2025-02-20 2024-11-12 2024-08-07 2024-05-02 2024-02-27
1234
Revenue 219.7 49.09 61.55 49.3 59.73 21.01 5.45
1234
Cost of Revenue 14.88 3.53 5.55 3.34 2.45 1.93 0.96
1234
Gross Profit 204.8 45.56 55.99 45.96 57.28 19.07 5.03
1234
Operating Expenses 469.5 126.1 137.3 103.9 102.2 113 103.5
1234
Research & Development 196.5 49.59 60.24 42.3 44.36 53.62 43.65
1234
Selling, General and Administrative 273 76.5 77.1 61.6 57.84 59.38 59.84
1234
Other Operating Expenses 0 0 0 0 0 0 0
1234
Operating Income -264.7 -80.54 -81.34 -57.94 -44.92 -93.93 -98.46
1234
Net Non-Operating Interest 17.43 -0.998 5.43 6.22 6.78 7.57 5.98
1234
Interest Income 18.43 0 5.43 6.22 6.78 7.57 5.98
1234
Interest Expense 0.998 0.998 0 0 0 0 0
1234
Equity & Other Income/(Expense) -6.63 -1.65 -1.39 -1.81 -1.78 -1.02 -1.83
1234
Income Before Tax -253.9 -83.19 -77.3 -53.53 -39.92 -87.39 -94.32
1234
Income Tax Expense 0 0 0 0 0 0 0
1234
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0
1234
Net Income -253.9 -83.19 -77.3 -53.53 -39.92 -87.39 -94.32
1234
Depreciation and Amortization 3.84 1.1 1.02 0.878 0.844 0.729 0.538
1234
EBITDA -260.9 -79.44 -80.33 -57.06 -44.08 -93.2 -97.92
1234
Earnings Per Share (EPS) -3.41 -1.11 -1.04 -0.72 -0.54 -1.18 -1.28
1234
Diluted Earnings Per Share -3.41 -1.11 -1.04 -0.72 -0.54 -1.18 -1.28
1234
Weighted Average Shares Outstanding 74.89 74.89 74.13 74.26 74.12 73.77 73.49
1234
Diluted Weighted Average Shares Outstanding 74.89 74.89 74.13 74.26 74.12 73.77 73.49
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program